Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells

Anderson, 1997, A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function, Nature, 390, 175, 10.1038/36593

Borden, 1997, Transcriptional control of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases, Crit Rev Eukaryot Gene Exp, 7, 159, 10.1615/CritRevEukarGeneExpr.v7.i1-2.90

Brändström, 1998, Regulation of osteoprotegerin mRNA levels by prostaglandin E2 in human bone marrow stroma cells, Biochem Biophys Res Commun, 247, 338, 10.1006/bbrc.1998.8783

Brändström, 1998, Tumor necrosis factor-α and -β upregulate the levels of osteoprotegerin mRNA in human osteosarcoma MG-63 cells, Biochem Biophys Res Commun, 248, 454, 10.1006/bbrc.1998.8993

Bucay, 1998, Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification, Genes Dev, 12, 1260, 10.1101/gad.12.9.1260

Dinarello, 1996, Biologic basis for interleukin-1 in disease, Blood, 87, 2095, 10.1182/blood.V87.6.2095.bloodjournal8762095

Feinberg, 1983, A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity, Anal Biochem, 132, 6, 10.1016/0003-2697(83)90418-9

Fuller, 1998, TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts, J Exp Med, 188, 997, 10.1084/jem.188.5.997

Hicok, 1998, Development and characterization of conditionally immortalized osteoblast precursor cell lines from human bone marrow stroma, J Bone Miner Res, 13, 205, 10.1359/jbmr.1998.13.2.205

Hing, 1998, Mechanisms by which NF-κB regulates osteoclast numbers, Bone, 23, S190

Hofbauer, 1998, Osteoprotegerin and its cognate ligand, Eur J Endocrinol, 139, 152, 10.1530/eje.0.1390152

Hofbauer, 1998, Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines, Biochem Biophys Res Commun, 250, 776, 10.1006/bbrc.1998.9394

Hofbauer, L. C., Riggs, B. L., Dunstan, C. R., Lacey, D. L., Spelsberg, T. C., and Khosla, S. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: Potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology. In press.

Hofbauer, 1998, Estrogen stimulates production of the antiresorptive cytokine receptor osteoprotegerin in human osteoblastic cells, Bone, 23, S172

Jilka, 1998, Cytokines, bone remodeling, and estrogen deficiency, Bone, 23, 75, 10.1016/S8756-3282(98)00077-5

Kassem, 1996, Cytokine production in the bone marrow microenvironment, J Clin Endocrinol Metab, 81, 513, 10.1210/jc.81.2.513

Kimble, 1996, Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1 and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor, J Biol Chem, 271, 28890, 10.1074/jbc.271.46.28890

Kong, 1999, OPGL is a key regulator of osteoclastogenesis, lymphocyte development, and lymph-node organogenesis, Nature, 397, 315, 10.1038/16852

Kwon, 1998, TR1, a new member of the tumor necrosis factor receptor family, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption, FASEB J, 12, 845, 10.1096/fasebj.12.10.845

Lacey, 1998, Osteoprotegerin (OPG) ligand is a cytokine that regulates osteoclast differentiation and activation, Cell, 93, 165, 10.1016/S0092-8674(00)81569-X

Lehrach, 1977, RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination, Biochemistry, 16, 4743, 10.1021/bi00640a033

Manolagas, 1995, Bone marrow, cytokines, and bone remodeling, N Engl J Med, 332, 305, 10.1056/NEJM199502023320506

Mizuno, 1998, Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin, Biochem Biophys Res Commun, 247, 610, 10.1006/bbrc.1998.8697

Nishimura, 1998, Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cells, J Bone Miner Res, 13, 777, 10.1359/jbmr.1998.13.5.777

Pacifici, 1996, Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis, J Bone Miner Res, 11, 1043, 10.1002/jbmr.5650110802

Quinn, 1998, A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro, Endocrinology, 139, 4424, 10.1210/en.139.10.4424

Romas, 1996, The role of gp130-mediated signals in osteoclast development, J Exp Med, 183, 2581, 10.1084/jem.183.6.2581

Simonet, 1997, Osteoprotegerin, Cell, 89, 309, 10.1016/S0092-8674(00)80209-3

Takai, 1998, Transforming growth factor-β stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells, J Biol Chem, 273, 27091, 10.1074/jbc.273.42.27091

Tan, 1997, Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells, Gene, 204, 35, 10.1016/S0378-1119(97)00509-X

Thomas, 1980, Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose, Proc Natl Acad Sci USA, 77, 5201, 10.1073/pnas.77.9.5201

Tsukii, 1998, Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1α,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone, Biochem Biophys Res Commun, 246, 337, 10.1006/bbrc.1998.8610

van Deuren, 1997, The pattern of interleukin-1beta (IL-1beta) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections, Blood, 90, 1101, 10.1182/blood.V90.3.1101

Vidal, 1998, Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells, J Endocrinol, 159, 191, 10.1677/joe.0.1590191

Vidal, 1998, Osteoprotegerin mRNA is increased by interleukin-α in the human osteosarcoma cell line MG-63 and in human osteoblast-like cells, Biochem Biophys Res Commun, 248, 696, 10.1006/bbrc.1998.9035

Wong, 1997, TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-jun N-terminal kinase in T cells, J Biol Chem, 272, 25190, 10.1074/jbc.272.40.25190

Yasuda, 1998, Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL, Proc Natl Acad Sci USA, 95, 3597, 10.1073/pnas.95.7.3597

Yasuda, 1998, Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG), Endocrinology, 139, 1329, 10.1210/en.139.3.1329